WealthShield Partners LLC Boosts Stock Holdings in UnitedHealth Group Incorporated $UNH

WealthShield Partners LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,382 shares of the healthcare conglomerate’s stock after purchasing an additional 2,303 shares during the quarter. WealthShield Partners LLC’s holdings in UnitedHealth Group were worth $4,418,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. Guerra Advisors Inc purchased a new position in UnitedHealth Group in the third quarter worth about $1,059,000. Phoenix Financial Ltd. boosted its stake in UnitedHealth Group by 111.5% during the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock valued at $14,282,000 after purchasing an additional 22,137 shares during the last quarter. Money Concepts Capital Corp increased its holdings in UnitedHealth Group by 59.1% in the 3rd quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate’s stock worth $4,275,000 after buying an additional 4,600 shares in the last quarter. Public Sector Pension Investment Board boosted its holdings in shares of UnitedHealth Group by 43.1% during the 3rd quarter. Public Sector Pension Investment Board now owns 287,132 shares of the healthcare conglomerate’s stock valued at $99,147,000 after acquiring an additional 86,432 shares during the last quarter. Finally, Compass Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $13,691,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Zacks Research raised near‑term and FY‑2026 EPS forecasts (Q2 2026 to $4.94 from $4.74; FY‑2026 to $18.26), signaling stronger near‑term earnings momentum and reinforcing consensus that 2026 will be a recovery year. (Zacks estimate revisions — MarketBeat / summary)
• Positive Sentiment: UnitedHealthcare will eliminate prior‑authorization requirements for roughly 30% of services starting in 2026 — a large operational change that should reduce administrative friction, improve member/provider experience and potentially lower costs over time. This is being viewed favorably by the market. UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock
• Positive Sentiment: Goldman Sachs added UNH to its U.S. Conviction List and kept a $435 price target — a high‑profile vote of confidence that likely supports buying interest. Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
• Positive Sentiment: Managerial actions and fundamentals: analysts and commentators point to increased share buybacks and an improved Q1 that lifted guidance — themes that support multiple expansion and investor confidence. Why UnitedHealth Group Stock Came Roaring Back In April
• Neutral Sentiment: Sector context — peers Tenet (THC) beat Q1 but face payer‑mix pressure, and CVS reported strong Health Benefits results tied to ACA exits/premium actions; these moves can influence industry pricing and utilization dynamics but are not direct UNH fundamentals. THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups ’26 EPS View CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
• Neutral Sentiment: Talent movement: a former UnitedHealth executive, Heather Cianfrocco, was appointed COO at Highmark — notable for industry networking but not currently viewed as material to UNH’s strategy. Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
• Negative Sentiment: Zacks also trimmed a few longer‑term quarter/year estimates (small cuts to FY‑2027 and Q1‑2028), which could temper upside expectations for distant‑out periods even as near‑term outlook improved.

UnitedHealth Group Price Performance

NYSE:UNH opened at $367.11 on Thursday. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $395.52. The business’s 50-day simple moving average is $302.62 and its two-hundred day simple moving average is $316.89. The stock has a market cap of $333.41 billion, a PE ratio of 27.73, a P/E/G ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s revenue was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is 66.77%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. TD Cowen boosted their target price on shares of UnitedHealth Group from $311.00 to $337.00 and gave the company a “hold” rating in a research note on Thursday, April 23rd. Robert W. Baird boosted their price target on UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $389.00 to $420.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 7th. Finally, Barclays raised their target price on UnitedHealth Group from $327.00 to $373.00 and gave the stock an “overweight” rating in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $378.88.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.